Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Receivables (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 15 years of Receivables data on record, last reported at $190.5 million in Q4 2025.

  • For Q4 2025, Receivables rose 13.86% year-over-year to $190.5 million; the TTM value through Dec 2025 reached $190.5 million, up 13.86%, while the annual FY2025 figure was $194.3 million, 0.59% up from the prior year.
  • Receivables reached $190.5 million in Q4 2025 per PBH's latest filing, down from $199.0 million in the prior quarter.
  • Across five years, Receivables topped out at $199.0 million in Q3 2025 and bottomed at $114.7 million in Q1 2021.
  • Average Receivables over 5 years is $161.0 million, with a median of $161.0 million recorded in 2023.
  • Peak YoY movement for Receivables: tumbled 32.83% in 2021, then increased 21.68% in 2025.
  • A 5-year view of Receivables shows it stood at $134.3 million in 2021, then grew by 17.0% to $157.1 million in 2022, then grew by 10.95% to $174.3 million in 2023, then decreased by 4.02% to $167.3 million in 2024, then increased by 13.86% to $190.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $190.5 million in Q4 2025, $199.0 million in Q3 2025, and $168.4 million in Q2 2025.